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The stress-inducible 70-kDa heat shock protein (HSP70) is a highly conserved protein
with diverse intracellular and extracellular functions. In skeletal muscle, HSP70 is rapidly
induced in response to both non-damaging and damaging stress stimuli including exercise
and acute muscle injuries. This upregulation of HSP70 contributes to the maintenance
of muscle fiber integrity and facilitates muscle regeneration and recovery. Conversely,
HSP70 expression is decreased during muscle inactivity and aging, and evidence supports
the loss of HSP70 as a key mechanism which may drive muscle atrophy, contractile
dysfunction and reduced regenerative capacity associated with these conditions. To
date, the therapeutic benefit of HSP70 upregulation in skeletal muscle has been
established in rodent models of muscle injury, muscle atrophy, modified muscle use,
aging, and muscular dystrophy, which highlights HSP70 as a key therapeutic target for
the treatment of various conditions which negatively affect skeletal muscle mass and
function. This article will review these important findings and provide perspective on
the unanswered questions related to HSP70 and skeletal muscle plasticity which require
further investigation.
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INTRODUCTION
The 70 kDa heat shock protein (Hsp70/HSPA) family is one of
the most evolutionary conserved protein families across both
prokaryotic and eukaryotic organisms (Brocchieri et al., 2008).
Due to their key roles as molecular chaperones, members of the
Hsp70 family are most widely known for their involvement in
promoting cellular proteostasis and survival throughout the lifes-
pan and during periods of stress (Morimoto, 1991). However,
this important family of proteins possesses several additional
functions, including the regulation of various cell signaling path-
ways involved in cell growth and inflammation (Asea et al., 2000;
Nollen and Morimoto, 2002).
In humans, there are at least 13 different genes that encode
for distinct Hsp70 proteins, but which share a common domain
structure, includingHSPA1A, HSPA1B, HSPA1L, HSPA2, HSPA4,
HSPA4L, HSPA5, HSPA6, HSPA7, HSPA8, HSPA9, HSPA12A, and
HSPA14 (Kampinga et al., 2009). The protein products encoded
by these genes are localized to various subcellular compartments,
and differ in their pattern of expression across various tissues.
Among the most well studied Hsp70 family members are the con-
stitutively expressed 70 kDa heat shock cognate protein (HSC70
or HSC73), encoded by the HSPA8 gene, and the stress-inducible
Hsp70 family members, encoded for by theHSPA1A andHSPA1B
genes and whose protein products differ by only two amino
acids. Due to inconsistencies in nomenclature, the proteins pro-
duced by these inducible genes are referred to by several different
names. HSP70-1/HSP72/HSPA1/HSPA1A each refers to the pro-
tein product of HSPA1A, while HSP70-2/HSPA1B both refer
to the protein product of HSPA1B. Moreover, due to the high
homology of HSP70-1 and HSP70-2, and the belief that these are
fully interchangeable proteins, these proteins are often collectively
referred to as simply HSP70, or more commonly in the muscle
literature, as HSP72.
In the last decade, the importance of HSP70 in skeletal muscle
has gained significant attention, due to its induction in response
to various physiological and pathophysiological stimuli, and its
speculated role in the muscle adaptations to these stimuli. This
article will therefore, review the studies which have provided
key experimental evidence surrounding the biological functions
of HSP70 in skeletal muscle. More specifically, this article will
focus on the studies which have demonstrated its critical role
in (1) protecting against muscle damage, (2) promoting muscle
regeneration and recovery, and (3) maintaining skeletal muscle
mass and integrity. In doing so, the potential of HSP70-targeted
therapeutics for the treatment of both skeletal muscle injuries and
muscle wasting disorders will be highlighted. Importantly, since
the majority of these studies were performed in rodent mod-
els, the use of HSP70 in this article will be in reference to the
inducible HSP70 proteins encoded by the rodent Hspa1a and
Hspa1b genes.
HSP70 AND SKELETAL MUSCLE DAMAGE AND
REGENERATION
HSP70 OVEREXPRESSION
The inducible HSP70 is increased in skeletal muscle following var-
ious perturbations such as exercise (Hernando and Manso, 1997;
Milne and Noble, 2002; Morton et al., 2009) and muscle injury
(Senf et al., 2013), and during the periods of muscle re-growth
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and regeneration associated with these conditions (Selsby et al.,
2007; Senf et al., 2013). In contrast, HSP70 is decreased during
prolonged periods of muscle inactivity (Lawler et al., 2006; Chen
et al., 2007; Senf et al., 2008) when muscles undergo significant
remodeling to reduce myofiber size to match the reduced force
demands placed on the muscle. Due to these observations, HSP70
has long been considered to play an important role in regulating
skeletal muscle plasticity.
The first definitive evidence that HSP70 regulates skeletal mus-
cle plasticity was demonstrated through the use of muscle-specific
Hsp70 transgenic (Tg) mice, and was published by McArdle
et al. (2004). In this study, muscles from wild type (WT) mice
and Hsp70 Tg mice were damaged through inducing lengthen-
ing muscle contractions, and the morphological and functional
properties of these muscles subsequently compared. The authors
found that 3 days following the lengthening contraction pro-
tocol, muscles from Hsp70 Tg mice showed less muscle fiber
damage compared to WT, and reduced deficits in muscle spe-
cific force. At later time points Hsp70 Tg mice also showed
earlier muscle functional recovery than WT. Thus, these findings
demonstrate that upregulation of HSP70 is sufficient to protect
against muscle damage and enhance muscle functional recov-
ery. In a subsequent study, skeletal muscles from Hsp70 Tg mice
were also found to have enhanced morphological recovery fol-
lowing muscle injury induced via cryolesioning (Miyabara et al.,
2006). This study similarly linked their findings of enhanced
recovery in muscles overexpressing HSP70 to reduced muscle
damage in response to the injury stimulus. Markers of muscle
satellite cell-activation were also measured in injured muscles,
and found to be decreased in Hsp70 Tg mice compared to WT.
This finding was not surprising since the extent of satellite cell-
mediated repair should match the extent of muscle damage.
In a more recent study, muscles from Hsp70 Tg mice also dis-
played enhanced recovery of fiber cross-sectional area (CSA) and
function following a period of disuse muscle atrophy (Miyabara
et al., 2012). Thus, these studies together provide considerable
evidence that HSP70 upregulation is a feasible countermeasure
to protect against muscle damage and enhance the recovery
process.
A later study by Moresi et al. (2009) further demonstrated
a more specific role of HSP70 in the augmentation of mus-
cle fiber regeneration. In this study, HSP70 was overexpressed
specifically in regenerating myofibers via electroporation of an
Hsp70 expression plasmid into muscles 3 days following cryole-
sioning injury. Due to the timing of Hsp70 overexpression in
muscles post-injury, this therefore, bypassed and eliminated the
potential for ectopic HSP70 to interfere with the early dam-
age sequela. When the CSA of regenerating myofibers positive
for HSP70 or a control vector were measured and compared
in muscles 7 days post-injury (4 days following plasmid elec-
troporation), regenerating myofibers positive for HSP70 were
significantly larger. Thus, the data from this study provided
clear evidence that enhancing HSP70 expression post-injury can
enhance the muscle regenerative process. This is highly signifi-
cant from a therapeutic standpoint, since preventative treatments
to reduce muscle damage in the event of acute injury are often
unrealistic. Thus, HSP70-targeted therapeutics to enhancemuscle
regeneration and recovery may be particularly relevant to sports-
related skeletal muscle strains and contusions, traumatic muscle
injures and even spinal cord injury (SCI), since markers of regen-
eration were recently shown to be elevated in rat skeletal mus-
cle following moderate spinal cord contusion (Jayaraman et al.,
2013).
HSP70 KNOCKOUT
Collectively the studies discussed thus, far have provided key
experimental evidence that Hsp70 upregulation protects against
muscle damage and enhances the recovery process. However,
until just recently, it was not clear whether HSP70 is neces-
sary for the regenerative process, and whether a reduction in
HSP70 alone is sufficient to enhance muscle damage and inter-
fere with the regenerative process. This question is important
in that skeletal muscle expression of HSP70, and the ability
to induce its expression, is diminished with age concomitantly
with the age-related decline in muscle regenerative capacity and
rate of recovery following muscle damage (Vasilaki et al., 2002;
McArdle et al., 2004). The study byMcArdle et al. (2004) provided
important evidence that these two events may be linked, since
both adult and aged mice overexpressing HSP70 showed pro-
tection against muscle damage and enhanced functional recov-
ery. However, loss of function studies using gene knockdown
are also important in confirming this link, through establish-
ing the biological requirement of HSP70 for these skeletal muscle
processes. Therefore, my colleagues and I recently conducted
experiments using mice which lack the inducible HSP70 coded
for by Hspa1a and Hspa1b (Hsp70−/− mice). In these experi-
ments muscles from WT and Hsp70−/− mice were injured via
direct injection with cardiotoxin, which induces widespread mus-
cle fiber necrosis, and is thus, a standardized and reproducible
method to study the regenerative process. At various time points
following the injury stimulus the extent of muscle inflamma-
tion, necrosis, and regeneration were subsequently compared. We
found that injured muscles from Hsp70−/− mice had a signif-
icantly delayed inflammatory response to muscle injury which
was followed at later time points by sustained inflammation and
muscle fiber necrosis, fibrosis, and reduced CSA of regenerat-
ing myofibers (Senf et al., 2013). In addition, injured muscles
lacking HSP70 also developed widespread calcifications during
the recovery process. These findings therefore, provide strong
evidence that HSP70 is necessary for successful muscle regen-
eration and recovery, and further link the age-related impair-
ments in these critical skeletal muscle processes to deficits in
HSP70.
The mechanisms whereby HSP70 regulates muscle regener-
ation and recovery following injury are still being elucidated.
However, in our recent report we uncovered some important
mechanistic details. Based on rescue experiments introducing an
Hsp70 plasmid into muscles of Hsp70−/− mice either 4 days
prior to injury or 4 days post injury, we establish that HSP70
plays an especially critical role within the first 4 days following
injury to support the recovery process (Senf et al., 2013). The
first several days following muscle injury are dominated by a
highly coordinated inflammatory response involving the recruit-
ment of various immune cell populations including neutrophils
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and macrophages which support muscle regeneration and repair
(Tidball and Villalta, 2010). Infiltration of these immune cell pop-
ulations contribute to muscle healing in various capacities, and
their failure to infiltrate in a timely manner can certainly impede
the recovery process. One important role is their involvement
in the removal of necrotic cellular debris through phagocytosis,
which allows viable muscle cells to successfully repopulate dam-
aged areas. Since injured muscles from Hsp70−/− mice displayed
a significantly impaired ability to recruit these important phago-
cytic immune cells in a timely manner, we hypothesize that this
may have contributed to the persisting muscle inflammation and
fiber necrosis seen in these mice at later time points. This notion
is supported by the rescue experiments in which reintroduction
of HSP70 into muscles of Hsp70−/− mice prior to cardiotoxin
injury (but not post injury) prevented these deficits in muscle
recovery.
So exactly how does HSP70 expressed by skeletal muscle fibers
contribute to immune cell infiltration in response to injury?
One possibility is through the immunostimulatory functions of
HSP70 when localized to the extracellular environment. Studies
on tissue injury of the heart, liver and skin have in fact demon-
strated that HSP70 is released into the extracellular environment
following tissue injury and facilitates the activation of pro-
inflammatory processes and the recruitment of immune cells
to the injury site (Dybdahl et al., 2002, 2005; Kimura et al.,
2004; Kovalchin et al., 2006). Thus, a similar mechanism involv-
ing extracellular HSP70 may be involved in the inflammatory
response to muscle injury. While this concept has previously been
suggested by others (Lightfoot et al., 2009; Han et al., 2010), data
generated in our recent study were the first to support this notion.
In these experiments, recombinant HSP70 protein was directly
injected into muscles of Hsp70−/− mice at the time of injury
to simulate HSP70 release into the extracellular microenviron-
ment. Using this method, we were able to completely restore early
immune cell infiltration into injured muscles of Hsp70−/− mice,
thus, providing a novel link between the inflammatory response
to muscle injury and the extracellular functions of HSP70 (Senf
et al., 2013). However, our understanding of HSP70 and its
involvement in the inflammatory response to muscle injury is still
in its infancy. Thus, additional studies are needed to elucidate the
precise roles of HSP70 in the initiation of inflammatory processes
in damaged muscle, and how this modulates the regenerative
process.
As mentioned previously, the CSA of regenerating myofibers
in muscles from Hsp70−/− mice were significantly smaller than
WT (Senf et al., 2013). This indicates that HSP70 is necessary
for the normal muscle fiber regeneration, and complements the
previous findings of Moresi et al. (2009) which demonstrated
that HSP70 overexpression enhances the CSA of regenerating
myofibers. Although the mechanisms whereby HSP70 is neces-
sary for myofiber regeneration are currently unclear, markers
of satellite cell activation and proliferation in injured mus-
cles from Hsp70−/− mice were not significantly compromised.
Therefore, HSP70 may be dispensable for these early stages of
the myogenic program. In contrast, HSP70 could regulate later
stages of the myogenic program which support differentiation
and the formation of multinucleated myofibers. This notion is
supported by experiments from two separate studies in which
introduction of an Hsp70 plasmid into muscles 3 or 4 days fol-
lowing injury enhanced the CSA and nucleation of regenerating
myofibers (Moresi et al., 2009; Senf et al., 2013). However, as
mentioned previously, additional studies detailing the effect of
HSP70 overexpression and knockdown on each stage of the myo-
genic program are needed to better understand the role of HSP70
in these important cellular processes. Preferably, these experi-
ments would be performed in both skeletal muscle cells in vitro
and whole muscle, in vivo, to differentiate between the mus-
cle cell autonomous and non-autonomous mechanisms whereby
HSP70 regulates the muscle regenerative process following
injury.
HSP70 AND MUSCLE WASTING AND DYSFUNCTION
In addition to the roles of HSP70 in facilitating muscle regenera-
tion and recovery following injury, HSP70 also plays an important
role in regulating muscle fiber size under baseline conditions
and during conditions of muscle atrophy. Indeed, HSP70 is
decreased in both adult and aged rats during periods of muscle
disuse, and plasmid-mediated restoration of HSP70 expression
in muscles during the disuse period significantly inhibits the
associated fiber atrophy (Senf et al., 2008; Dodd et al., 2009).
These findings were linked to HSP70 negatively regulating the
Forkhead BoxO (FoxO) and Nuclear Factor κB (NF-κB) path-
ways, which are activated during multiple conditions of muscle
atrophy and which drive the atrophy phenotype (Cai et al.,
2004; Hunter and Kandarian, 2004; Sandri et al., 2004; Judge
et al., 2007; Senf et al., 2010; Reed et al., 2012). Thus, reduc-
tions in HSP70 during conditions of atrophy may contribute
to the atrophy phenotype through weakening the inhibition of
these signaling pathways. Evidence that HSP70 is necessary for
the maintenance of muscle fiber size and functional integrity
is demonstrated by the muscle phenotype of adult Hsp70−/−
mice, in which muscle fiber CSA and muscle specific force is
reduced when compared to controls (Senf et al., 2013). This is
further supported by evidence that the age-related decline in
muscle specific force is prevented in muscles of aged mice over-
expressing HSP70 throughout the lifespan (McArdle et al., 2004).
This regulation of skeletal muscle functional integrity by HSP70
may be related to the finding that muscles from Hsp70 Tg mice
also displayed enhanced antioxidant capacity (Broome et al.,
2006), since oxidative stress may contribute to muscle dysfunc-
tion during the aging process. In addition, and perhaps related
to this, HSP70 also appears to contribute to the maintenance
of skeletal muscle quality during normal physiological condi-
tions, since muscles from Hsp70−/− mice also had significant
increases in the amount of extracellular tissue (non-muscle fiber
tissue) surrounding the already smaller muscle fibers. The mech-
anisms responsible for the reduced fiber CSA in mice lacking
HSP70 throughout the lifespan are not known. However, since
induction of intracellular HSP70 represses pathways involved in
muscle atrophy and inflammation in skeletal muscle (Chung
et al., 2008; Senf et al., 2008), the lack of HSP70 may con-
tribute to increases in these signaling pathways under baseline
conditions. Alternatively, deficits in post-natal muscle growth in
mice could play a role in this finding, since Hsp70−/− mice had
www.frontiersin.org November 2013 | Volume 4 | Article 330 | 3
Senf HSP70 and skeletal muscle plasticity
Table 1 | List of studies which have directly manipulated Hsp70 expression to investigate the functions of Hsp70 in regulating skeletal
muscle plasticity.
Condition/model Skeletal muscle phenotype References
Hsp70 OVEREXPRESSION
Hsp70 transgenic mice 10–12 months adult mice Decreased body and muscle mass McArdle et al., 2004
Aging Preservation of muscle specific force McArdle et al., 2004
Muscle damage/eccentric
contractions
Decreased muscle damage, improved muscle functional
recovery (adult and old mice)
McArdle et al., 2004
Muscle damage/cryolesioning Decreased muscle damage, improved morphological recovery Miyabara et al., 2006
Modified muscle use/cast-
immobilization and recovery
Improved muscle structural and functional recovery Miyabara et al., 2012
Muscular dystrophy/crossed
with mdx mice
Improved muscle morphology and function Gehrig et al., 2012
Hsp70 plasmid
electroporation
Muscle
atrophy/cast-immobilization
Attenuation of disuse muscle fiber atrophy (adult and old rats) Senf et al., 2008; Dodd
et al., 2009
Muscle damage/freeze injury Increased CSA of regenerating muscle fibers Moresi et al., 2009
Hsp70 KNOCKDOWN
Hsp70 knockout mice 12–15 weeks adult mice Decreased muscle fiber CSA, decreased muscle specific force Senf et al., 2013
Muscle damage/direct
cardiotoxin injection
Delayed inflammatory response to injury, impaired muscle
regeneration and recovery (smaller CSA of regenerating fibers,
sustained inflammation, fibrosis and calcium deposition)
Senf et al., 2013
Modified muscle
use/cast-immobilization and
recovery
Decreased muscle reloading damage, decreased size of
regenerating fibers
Senf et al., 2013
deficits in the growth of regenerating myofibers, and both pro-
cesses rely upon related cellular mechanisms to support fiber
growth. Clearly, numerous unanswered questions still remain sur-
rounding the mechanisms in which HSP70 regulates muscle fiber
size and function. Nonetheless, these collective studies confirm
that HSP70 is necessary for the maintenance of muscle fiber size
and functional integrity, and highlight HSP70 upregulation as a
key therapeutic strategy that may be beneficial during various
skeletal muscle wasting disorders to maintain muscle mass and
function.
One highly significant study surrounding the use of HSP70-
targeted therapeutics for genetic muscle wasting disorders was
recently published by Gehrig et al. (2012). In this study, the
authors demonstrate that upregulation of the inducible HSP70 in
mouse skeletal muscle (through either genetic or pharmacolog-
ical means) ameliorates the dystrophic phenotype. This finding
was demonstrated in two models of muscular dystrophy related
to the absence of dystrophin, including the mdx model and
the more severe dko model in which utrophin is also absent.
Importantly, treatment of dystrophic mice with BGP-15, a phar-
macological co-inducer of HSP70 that is currently being used in
clinical trials, improved the dystrophic pathology of both limb
and diaphragm muscles and extended lifespan. Thus, BGP-15
and other pharmacological inducers of HSP70 may be key thera-
peutic agents for muscular dystrophies. The mechanism whereby
HSP70 improved the dystrophy phenotype in this study was
linked to its regulation of the sarcoplasmic/endoplasmic reticu-
lum Ca(2+)-ATPase (SERCA) protein, whose activity is compro-
mised in severely dystrophic muscle. The activity of SERCA is
critical in removing intracellular calcium, and HSP70 was found
to interact with and enhance SERCA activity. Since increased
intracellular calcium is a key activator of inflammatory and
muscle degenerative pathways, maintenance of SERCA activ-
ity was proposed to be a key mechanism for the amelioration
of the dystrophic phenotype in muscles overexpressing HSP70.
However, since HSP70 also negatively regulates muscle atro-
phy pathways, enhances regenerative processes and promotes a
timely and controlled inflammatory response to muscle damage,
the beneficial effects of HSP70 upregulation on the dystrophic
pathology could also be related to these additional skeletal muscle
functions of HSP70. Regardless of the mechanism, the findings
from this study clearly indicate that HSP70-targeted therapeutics
have significant potential for the treatment of dystrophic muscle
pathologies.
CONCLUSION
In summary, the inducible HSP70 is a critical skeletal muscle
protein that positively regulates muscle size and function during
health and disease. The studies which directly support this notion
are summarized in Table 1. While several questions still remain
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surrounding the mechanisms responsible for this regulation, it is
clear that therapeutics targeting HSP70 upregulation have strong
potential for success in the treatment of both acquired and genetic
muscle wasting disorders and in the treatment of muscle injuries.
However, future studies should continue to delineate the cellular
mechanisms whereby HSP70 regulates skeletal muscle plastic-
ity. These studies are important not only from a mechanistic
standpoint, but from a therapeutic standpoint, since the timing of
HSP70 induction, route of administration, and duration of treat-
ment to optimally enhance therapeutic benefits may be revealed
from knowledge gained through these studies.
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